Oncolytics Biotech Inc. (NASDAQ: ONCY) announced that insider Thomas Charles Heineman purchased 12,132 shares of the company’s stock on February 12, 2024. This transaction, valued at...
The cancer drugs market is projected to reach a staggering $594.3 billion by 2035, largely due to the rise of precision technologies and advanced immunotherapies that...